166 related articles for article (PubMed ID: 34942515)
1. Long non-coding RNAs (lncRNAs) as prognostic and diagnostic biomarkers in multiple myeloma: A systematic review and meta-analysis.
Mardani M; Rashedi S; Keykhaei M; Farrokhpour H; Azadnajafabad S; Tavolinejad H; Rezaei N
Pathol Res Pract; 2022 Jan; 229():153726. PubMed ID: 34942515
[TBL] [Abstract][Full Text] [Related]
2. Aberrantly expressed long noncoding RNAs as potential prognostic biomarkers in newly diagnosed multiple myeloma: A systemic review and meta-analysis.
Qin J; Ke B; Liu T; Kong C; Li A; Fu H; Jin C
Cancer Med; 2023 Feb; 12(3):2199-2218. PubMed ID: 36057947
[TBL] [Abstract][Full Text] [Related]
3. The diagnostic and prognostic value of exosome-derived long non-coding RNAs in cancer patients: a meta-analysis.
Mu H; Zhang S; Yao Z; Liu Y; Lin K; Zhao Z; Zhu Y
Clin Exp Med; 2020 Aug; 20(3):339-348. PubMed ID: 32504320
[TBL] [Abstract][Full Text] [Related]
4. The Prognostic Role of Cyclin D1 in Multiple Myeloma: A Systematic Review and Meta-Analysis.
Jiang Y; Zhang C; Lu L; Wang X; Liu H; Jiang Y; Hong L; Chen Y; Huang H; Guo D
Technol Cancer Res Treat; 2022; 21():15330338211065252. PubMed ID: 35098809
[No Abstract] [Full Text] [Related]
5. Prognostic and diagnostic significance of lncRNAs expression in cervical cancer: a systematic review and meta-analysis.
Chi S; Shen L; Hua T; Liu S; Zhuang G; Wang X; Zhou X; Wang G; Wang H
Oncotarget; 2017 Oct; 8(45):79061-79072. PubMed ID: 29108287
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA as a potential diagnostic and prognostic biomarker in melanoma: A systematic review and meta-analysis.
Masrour M; Khanmohammadi S; Fallahtafti P; Hashemi SM; Rezaei N
J Cell Mol Med; 2024 Feb; 28(3):e18109. PubMed ID: 38193829
[TBL] [Abstract][Full Text] [Related]
7. Abnormally Expressed Long Non-Coding RNAs in Nasopharyngeal Carcinoma: a Meta-Analysis.
Xia L; Zhang W; Zhu L; Yu G
Clin Lab; 2018 Apr; 64(4):585-595. PubMed ID: 29739093
[TBL] [Abstract][Full Text] [Related]
8. LncRNAs act as prognostic and diagnostic biomarkers in renal cell carcinoma: a systematic review and meta-analysis.
Chen J; Chen Y; Gu L; Li X; Gao Y; Lyu X; Chen L; Luo G; Wang L; Xie Y; Duan J; Peng C; Ma X
Oncotarget; 2016 Nov; 7(45):74325-74336. PubMed ID: 27527868
[TBL] [Abstract][Full Text] [Related]
9. TUG1, SPRY4-IT1, and HULC as valuable prognostic biomarkers of survival in cancer: A PRISMA-compliant meta-analysis.
Zhong Y; Chen Z; Guo S; Liao X; Xie H; Zheng Y; Cai B; Huang P; Liu Y; Zhou Q; Liu Y; Huang W
Medicine (Baltimore); 2017 Nov; 96(46):e8583. PubMed ID: 29145271
[TBL] [Abstract][Full Text] [Related]
10. The prognostic value of long non coding RNAs in non small cell lung cancer: A meta-analysis.
Wang M; Ma X; Zhu C; Guo L; Li Q; Liu M; Zhang J
Oncotarget; 2016 Dec; 7(49):81292-81304. PubMed ID: 27833074
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of long non-coding RNAs in clear cell renal cell carcinoma: A meta-analysis.
Wang Y; Li Z; Li W; Zhou L; Jiang Y
Medicine (Baltimore); 2019 Oct; 98(40):e17276. PubMed ID: 31577719
[TBL] [Abstract][Full Text] [Related]
12. Investigating the diagnostic performance of HOTTIP, PVT1, and UCA1 long noncoding RNAs as a predictive panel for the screening of colorectal cancer patients with lymph node metastasis.
Gharib E; Anaraki F; Baghdar K; Ghavidel P; Sadeghi H; Nasrabadi PN; Peyravian N; Aghdaei HA; Zali MR; Mojarad EN
J Cell Biochem; 2019 Sep; 120(9):14780-14790. PubMed ID: 30993787
[TBL] [Abstract][Full Text] [Related]
13. lncRNAs as prognostic molecular biomarkers in hepatocellular carcinoma: a systematic review and meta-analysis.
Zheng C; Liu X; Chen L; Xu Z; Shao J
Oncotarget; 2017 Aug; 8(35):59638-59647. PubMed ID: 28938667
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of long non-coding RNAs in triple negative breast cancer: A PRISMA-compliant meta-analysis.
Zhang S; Ma F; Xie X; Shen Y
Medicine (Baltimore); 2020 Sep; 99(37):e21861. PubMed ID: 32925722
[TBL] [Abstract][Full Text] [Related]
15. Prognostic and diagnostic values of non-coding RNAs as biomarkers for breast cancer: An umbrella review and pan-cancer analysis.
Bahramy A; Zafari N; Rajabi F; Aghakhani A; Jayedi A; Khaboushan AS; Zolbin MM; Yekaninejad MS
Front Mol Biosci; 2023; 10():1096524. PubMed ID: 36726376
[No Abstract] [Full Text] [Related]
16. Identification and validation of potential prognostic lncRNA biomarkers for predicting survival in patients with multiple myeloma.
Zhou M; Zhao H; Wang Z; Cheng L; Yang L; Shi H; Yang H; Sun J
J Exp Clin Cancer Res; 2015 Sep; 34(1):102. PubMed ID: 26362431
[TBL] [Abstract][Full Text] [Related]
17. Clinical Values of Long Non-coding RNAs in Bladder Cancer: A Systematic Review.
Su G; He Q; Wang J
Front Physiol; 2018; 9():652. PubMed ID: 29899709
[No Abstract] [Full Text] [Related]
18. Circulating long non-coding RNAs as novel diagnostic biomarkers for Alzheimer's disease (AD): A systematic review and meta-analysis.
Shobeiri P; Alilou S; Jaberinezhad M; Zare F; Karimi N; Maleki S; Teixeira AL; Perry G; Rezaei N
PLoS One; 2023; 18(3):e0281784. PubMed ID: 36947499
[TBL] [Abstract][Full Text] [Related]
19. Abnormally expressed long non-coding RNAs in prognosis of Osteosarcoma: A systematic review and meta-analysis.
Chen D; Wang H; Zhang M; Jiang S; Zhou C; Fang B; Chen P
J Bone Oncol; 2018 Nov; 13():76-90. PubMed ID: 30591861
[TBL] [Abstract][Full Text] [Related]
20. The prognostic value of abnormally expressed lncRNAs in colorectal cancer: A meta-analysis.
Wang J; Du S; Wang J; Fan W; Wang P; Zhang Z; Xu P; Tang S; Deng Q; Yang W; Yu M
PLoS One; 2017; 12(6):e0179670. PubMed ID: 28658310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]